Refractory Melanoma clinical trials

Explore recruiting refractory melanoma clinical trials.

Recruiting refractory melanoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizuma Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02B

Spain, France, Greece, Poland, Italy, Hungary

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1/2 Open-label, Rolling-arm, Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants with Melanoma (KEYMAKER-U02): Substudy 02A

France, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A two-part, open-label, clinical study to assess the safety, tolerability and activity of intravenous doses of ICT01 in combination with low-dose subcutaneous interleukin-2 in patients with advanced solid tumors (EVICTION-2)

France, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Refractory Melanoma trials by city

Refractory Melanoma in Toronto Refractory Melanoma in Vancouver Refractory Melanoma in Montreal Refractory Melanoma in Calgary Refractory Melanoma in Edmonton Refractory Melanoma in Ottawa Refractory Melanoma in Winnipeg Refractory Melanoma in Quebec City Refractory Melanoma in Hamilton Refractory Melanoma in Kitchener Refractory Melanoma in London Refractory Melanoma in Halifax Refractory Melanoma in New York Refractory Melanoma in Los Angeles Refractory Melanoma in Chicago Refractory Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease